Last reviewed · How we verify
Hydrogen Peroxide Gel, 13 weeks
Hydrogen Peroxide Gel, 13 weeks is a Small molecule drug developed by Loma Linda University. It is currently FDA-approved. Also known as: Perio Protect®, 1.7% hydrogen peroxide gel.
At a glance
| Generic name | Hydrogen Peroxide Gel, 13 weeks |
|---|---|
| Also known as | Perio Protect®, 1.7% hydrogen peroxide gel |
| Sponsor | Loma Linda University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Hydrogen Peroxide Gel, 13 weeks CI brief — competitive landscape report
- Hydrogen Peroxide Gel, 13 weeks updates RSS · CI watch RSS
- Loma Linda University portfolio CI
Frequently asked questions about Hydrogen Peroxide Gel, 13 weeks
What is Hydrogen Peroxide Gel, 13 weeks?
Hydrogen Peroxide Gel, 13 weeks is a Small molecule drug developed by Loma Linda University.
Who makes Hydrogen Peroxide Gel, 13 weeks?
Hydrogen Peroxide Gel, 13 weeks is developed and marketed by Loma Linda University (see full Loma Linda University pipeline at /company/loma-linda-university).
Is Hydrogen Peroxide Gel, 13 weeks also known as anything else?
Hydrogen Peroxide Gel, 13 weeks is also known as Perio Protect®, 1.7% hydrogen peroxide gel.
What development phase is Hydrogen Peroxide Gel, 13 weeks in?
Hydrogen Peroxide Gel, 13 weeks is FDA-approved (marketed).
Related
- Manufacturer: Loma Linda University — full pipeline
- Also known as: Perio Protect®, 1.7% hydrogen peroxide gel
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing